Product News and Recalls

Further studies needed about risks of testosterone therapy

A report from CBS News suggests further studies are needed to assess the risks of testosterone therapy.

Testosterone therapy, also called androgen replacement therapy, was approved by the Food and Drug Administration as a way for men to improve health. However, there is little data on its long-term effects. Previous studies indicate that testosterone therapy is associated with an increased risk of heart attack, stroke, and death.

According to CBS News, the American Medical Association Journal published a study recently that looked at older men in the Veterans Affairs system, and found that “there was a 29% increased risk of heart , stroke, or death in those given testosterone.”

However, a cardiologist from the Cleveland Clinic believes that further studies must be conducted in order to better assess the risk/benefit analysis of testosterone therapy. The current data for long-term effects of Testosterone therapy is minimal. A urologist from a hospital in New York City recommends that health care physicians think twice before treating patients with testosterone.

You should consult with a doctor before changing your medication or if you have any health concerns. Lopez McHugh is investigating cases of stroke, heart attack, and death while on Testosterone therapy such as Androgel, Axiron, Fortesta, Straint, or Testrium. If you or a loved one suffered one of these injuries, contact us for a free case evaluation.